PT2745837T - Tratamento de glomerulonefrite - Google Patents
Tratamento de glomerulonefriteInfo
- Publication number
- PT2745837T PT2745837T PT141584219T PT14158421T PT2745837T PT 2745837 T PT2745837 T PT 2745837T PT 141584219 T PT141584219 T PT 141584219T PT 14158421 T PT14158421 T PT 14158421T PT 2745837 T PT2745837 T PT 2745837T
- Authority
- PT
- Portugal
- Prior art keywords
- glomerulonephritis
- treatment
- glomerulonephritis treatment
- Prior art date
Links
- 206010018364 Glomerulonephritis Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/227—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0909643A GB0909643D0 (en) | 2009-06-04 | 2009-06-04 | Glomerulonephritis treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2745837T true PT2745837T (pt) | 2016-08-22 |
Family
ID=40936918
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT141584219T PT2745837T (pt) | 2009-06-04 | 2010-06-04 | Tratamento de glomerulonefrite |
| PT107226433T PT2437739E (pt) | 2009-06-04 | 2010-06-04 | Tratamento de glomerulonefrite |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT107226433T PT2437739E (pt) | 2009-06-04 | 2010-06-04 | Tratamento de glomerulonefrite |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US8796251B2 (enExample) |
| EP (2) | EP2437739B1 (enExample) |
| JP (1) | JP5837481B2 (enExample) |
| AU (1) | AU2010256013B2 (enExample) |
| CA (1) | CA2764465C (enExample) |
| CY (1) | CY1118269T1 (enExample) |
| DK (2) | DK2437739T3 (enExample) |
| ES (2) | ES2546198T3 (enExample) |
| GB (1) | GB0909643D0 (enExample) |
| HU (2) | HUE030085T2 (enExample) |
| LT (1) | LT2745837T (enExample) |
| PL (2) | PL2437739T3 (enExample) |
| PT (2) | PT2745837T (enExample) |
| WO (1) | WO2010139482A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201014633D0 (en) | 2010-09-02 | 2010-10-13 | Avexxin As | Rheumatoid arthritis treatment |
| GB201205394D0 (en) | 2012-03-27 | 2012-05-09 | Adlens Ltd | Improvements in or relating to deformable non-round membrane assemblies |
| GB201221329D0 (en) * | 2012-11-27 | 2013-01-09 | Avexxin As | Dermatitis treatment |
| GB201313238D0 (en) | 2013-07-24 | 2013-09-04 | Avexxin As | Process for the preparation of a polyunsaturated ketone compound |
| GB201409363D0 (en) | 2014-05-27 | 2014-07-09 | Avexxin As | Skin cancer treatment |
| GB201501144D0 (en) | 2015-01-23 | 2015-03-11 | Avexxin As | Process for the preparation of a polyunsaturated ketone compound |
| GB201604316D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| CA3037582A1 (en) | 2016-09-21 | 2018-03-29 | Avexxin As | Pharmaceutical composition |
| JP7305562B2 (ja) * | 2017-06-16 | 2023-07-10 | アヴェクシン エーエス | 線維性疾患の治療のための組成物および方法 |
| GB201910644D0 (en) | 2019-07-25 | 2019-09-11 | Coegin Pharma As | Cancer Treatment |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4670465A (en) * | 1986-05-21 | 1987-06-02 | Syntex (U.S.A.) Inc. | Arachidonic acid analogs |
| JPH0987176A (ja) * | 1995-09-26 | 1997-03-31 | Shiseido Co Ltd | 糸球体腎炎抑制剤 |
| JPH09268153A (ja) | 1996-04-02 | 1997-10-14 | Sagami Chem Res Center | トリフルオロメチルケトン誘導体及びホスホリパーゼａ２阻害剤 |
| US6262119B1 (en) * | 1996-04-12 | 2001-07-17 | Peptide Technology Limited | Methods of treating immunopathologies using polyunsaturated fatty acids |
| US6107334A (en) | 1998-02-23 | 2000-08-22 | Wake Forest University | Dietary control of arachidonic acid metabolism |
| US7605149B1 (en) | 1998-07-13 | 2009-10-20 | University Of South Florida | Modulation of the phospholipase A2 pathway as a therapeutic |
| US6031014A (en) | 1998-12-08 | 2000-02-29 | Crivello; James V. | Initiator compositions and methods for their synthesis and use |
| WO2002060535A1 (en) * | 2001-01-31 | 2002-08-08 | Leff Alan R | Method of treating inflammatory conditions by inhibiting cytosolic phospholipase a¿2? |
| GB0202002D0 (en) * | 2002-01-29 | 2002-03-13 | Leiv Eiriksson Nyotek A S | Use |
| MY131170A (en) * | 2002-03-28 | 2007-07-31 | Nissan Chemical Ind Ltd | Therapeutic agent for glomerular disease |
| CA2516142A1 (en) * | 2003-03-18 | 2004-09-30 | Novartis Ag | Compositions comprising fatty acids and amino acids |
| EP2114397A4 (en) * | 2006-12-20 | 2013-06-12 | Medwell Lab Ltd | NEW CONJUGATES OF MULTIPLE UNSATURATED FATTY ACIDS WITH AMINES AND ITS THERAPEUTIC USES |
| NZ552238A (en) * | 2006-12-20 | 2009-07-31 | Seperex Nutritionals Ltd | An extract |
| WO2009061208A1 (en) * | 2007-11-09 | 2009-05-14 | Pronova Biopharma Norge As | Lipid compounds for use in cosmetic products, as food supplement or as a medicament |
-
2009
- 2009-06-04 GB GB0909643A patent/GB0909643D0/en not_active Ceased
-
2010
- 2010-06-04 LT LTEP14158421.9T patent/LT2745837T/lt unknown
- 2010-06-04 US US12/794,367 patent/US8796251B2/en active Active
- 2010-06-04 WO PCT/EP2010/003384 patent/WO2010139482A1/en not_active Ceased
- 2010-06-04 ES ES10722643.3T patent/ES2546198T3/es active Active
- 2010-06-04 EP EP10722643.3A patent/EP2437739B1/en not_active Not-in-force
- 2010-06-04 PT PT141584219T patent/PT2745837T/pt unknown
- 2010-06-04 HU HUE14158421A patent/HUE030085T2/en unknown
- 2010-06-04 AU AU2010256013A patent/AU2010256013B2/en not_active Ceased
- 2010-06-04 PT PT107226433T patent/PT2437739E/pt unknown
- 2010-06-04 ES ES14158421.9T patent/ES2587719T3/es active Active
- 2010-06-04 CA CA2764465A patent/CA2764465C/en active Active
- 2010-06-04 PL PL10722643T patent/PL2437739T3/pl unknown
- 2010-06-04 DK DK10722643.3T patent/DK2437739T3/en active
- 2010-06-04 HU HUE10722643A patent/HUE027050T2/en unknown
- 2010-06-04 US US13/375,618 patent/US20120136066A1/en not_active Abandoned
- 2010-06-04 DK DK14158421.9T patent/DK2745837T3/en active
- 2010-06-04 JP JP2012513512A patent/JP5837481B2/ja not_active Expired - Fee Related
- 2010-06-04 EP EP14158421.9A patent/EP2745837B1/en not_active Not-in-force
- 2010-06-04 PL PL14158421T patent/PL2745837T3/pl unknown
-
2014
- 2014-03-07 US US14/200,238 patent/US9187396B2/en not_active Expired - Fee Related
-
2016
- 2016-08-24 CY CY20161100833T patent/CY1118269T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1118269T1 (el) | 2017-06-28 |
| DK2437739T3 (en) | 2015-08-17 |
| US20120136066A1 (en) | 2012-05-31 |
| WO2010139482A1 (en) | 2010-12-09 |
| LT2745837T (lt) | 2016-10-25 |
| AU2010256013A1 (en) | 2012-01-12 |
| PL2745837T3 (pl) | 2017-01-31 |
| HUE027050T2 (en) | 2016-08-29 |
| PT2437739E (pt) | 2015-10-12 |
| CA2764465A1 (en) | 2010-12-09 |
| PL2437739T3 (pl) | 2015-11-30 |
| JP2012528813A (ja) | 2012-11-15 |
| ES2587719T3 (es) | 2016-10-26 |
| HUE030085T2 (en) | 2017-04-28 |
| EP2745837B1 (en) | 2016-07-27 |
| US20140256824A1 (en) | 2014-09-11 |
| CA2764465C (en) | 2018-03-20 |
| EP2437739B1 (en) | 2015-07-29 |
| GB0909643D0 (en) | 2009-07-22 |
| DK2745837T3 (en) | 2016-08-29 |
| EP2745837A1 (en) | 2014-06-25 |
| US8796251B2 (en) | 2014-08-05 |
| JP5837481B2 (ja) | 2015-12-24 |
| US20100311843A1 (en) | 2010-12-09 |
| AU2010256013B2 (en) | 2013-05-16 |
| EP2437739A1 (en) | 2012-04-11 |
| US9187396B2 (en) | 2015-11-17 |
| ES2546198T3 (es) | 2015-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2409634A4 (en) | ENDOSCOPE OF TREATMENT | |
| HUE056278T2 (hu) | Elhízás kezelése | |
| PL2652193T3 (pl) | Obróbka | |
| EP2415386A4 (en) | Borescope | |
| GB0920112D0 (en) | Treatment device | |
| EP2481336A4 (en) | ENDOSCOPE | |
| GB0915515D0 (en) | Treatment of vasculoproliferative conditions | |
| GB2475364B (en) | Endoscope | |
| PT2437739E (pt) | Tratamento de glomerulonefrite | |
| GB0920784D0 (en) | Novel use | |
| GB0900599D0 (en) | Treatment | |
| GB201013898D0 (en) | Well treatment | |
| GB201013573D0 (en) | Treatment | |
| IL213287A0 (en) | Treatment for glomerulonephritis | |
| GB0913968D0 (en) | Treatment | |
| GB201001521D0 (en) | Treatment | |
| PL2263454T3 (pl) | Kompozycja uzdatniająca | |
| GB0916997D0 (en) | Combination therapy | |
| GB0907973D0 (en) | Combination therapy | |
| GB201014097D0 (en) | Treatment | |
| GB0906010D0 (en) | Acne treatment | |
| GB0914581D0 (en) | Well treatment | |
| GB0916542D0 (en) | Well treatment | |
| GB0901423D0 (en) | Treatment | |
| GB0921303D0 (en) | Treatment process |